Viridian Therapeutics Files 2025 Annual Report
Ticker: VRDN · Form: ARS · Filed: Apr 17, 2026 · CIK: 0001590750
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
Viridian Therapeutics filed its 2025 ARS on 4/17/26. Check it out.
AI Summary
Viridian Therapeutics, Inc. filed its Annual Report to Security Holders (ARS) on April 17, 2026, for the period ending December 31, 2025. The company is based in Waltham, MA, and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides shareholders with a comprehensive overview of Viridian Therapeutics' performance and financial standing for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual report filing and does not contain new material information that would typically indicate a change in risk.
Key Players & Entities
- Viridian Therapeutics, Inc. (company) — Filer of the ARS
- 2025-12-31 (date) — Period of Report
- 2026-04-17 (date) — Filing Date
- WALTHAM MA 02453 (location) — Mailing and Business Address
FAQ
What is the CIK number for Viridian Therapeutics, Inc.?
The CIK number for Viridian Therapeutics, Inc. is 0001590750.
When was the ARS filing accepted by the SEC?
The ARS filing was accepted on 2026-04-17 at 08:05:50.
What is the SIC code for Viridian Therapeutics, Inc.?
The SIC code for Viridian Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the state of incorporation for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. is incorporated in Delaware (DE).
What is the fiscal year end for Viridian Therapeutics, Inc.?
The fiscal year end for Viridian Therapeutics, Inc. is December 31 (1231).
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 17, 2026 regarding Viridian Therapeutics, Inc.\DE (VRDN).